Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romidepsin in Refractory Gastric and Esophageal Cancers
NCT00098527Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Oct 2004
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in gastric cancer (GC), esophageal cancer, sponsored by National Cancer Institute. Started Oct 2004; status: terminated.
02
Drugs
romidepsin
03
Conditions
gastric cancer (GC)esophageal cancer
Beyond the preview
Go deeper on NCT00098527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098527.